M. J. Stevens

1.1k total citations
9 papers, 524 citations indexed

About

M. J. Stevens is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, M. J. Stevens has authored 9 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cell Biology. Recurrent topics in M. J. Stevens's work include Pain Mechanisms and Treatments (3 papers), Aldose Reductase and Taurine (3 papers) and Neurological and metabolic disorders (2 papers). M. J. Stevens is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Aldose Reductase and Taurine (3 papers) and Neurological and metabolic disorders (2 papers). M. J. Stevens collaborates with scholars based in United States, United Kingdom and Japan. M. J. Stevens's co-authors include Eva L. Feldman, D. A. Greene, Thommey P. Thomas, S. A. Lattimer, Douglas A. Greene, Anders A. F. Sima, T. Thomas, Mikiko Kamijo, Helen Ristic and Alan Merry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Gut.

In The Last Decade

M. J. Stevens

9 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. J. Stevens United States 8 300 130 93 89 88 9 524
V. Marinescu United States 9 148 0.5× 43 0.3× 80 0.9× 90 1.0× 74 0.8× 16 595
Wilson Hsieh United States 7 219 0.7× 79 0.6× 43 0.5× 132 1.5× 22 0.3× 7 419
J. D. Ward United Kingdom 7 194 0.6× 113 0.9× 114 1.2× 40 0.4× 18 0.2× 9 373
Joachim Maus Germany 10 493 1.6× 337 2.6× 85 0.9× 164 1.8× 34 0.4× 20 935
C. Di Massimo Italy 17 204 0.7× 33 0.3× 75 0.8× 118 1.3× 26 0.3× 33 708
Mary E. Maley United States 13 195 0.7× 122 0.9× 20 0.2× 156 1.8× 42 0.5× 14 769
H. Nowak Germany 6 221 0.7× 241 1.9× 65 0.7× 82 0.9× 25 0.3× 14 536
C. Vargas Spain 11 154 0.5× 44 0.3× 118 1.3× 168 1.9× 19 0.2× 17 529
Ann M. Poynten Australia 18 569 1.9× 154 1.2× 222 2.4× 262 2.9× 54 0.6× 52 1.1k
Irina Gurieva Russia 6 393 1.3× 340 2.6× 100 1.1× 84 0.9× 21 0.2× 18 648

Countries citing papers authored by M. J. Stevens

Since Specialization
Citations

This map shows the geographic impact of M. J. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. J. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. J. Stevens more than expected).

Fields of papers citing papers by M. J. Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. J. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. J. Stevens. The network helps show where M. J. Stevens may publish in the future.

Co-authorship network of co-authors of M. J. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of M. J. Stevens. A scholar is included among the top collaborators of M. J. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. J. Stevens. M. J. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Stevens, M. J., Eva L. Feldman, Thommey P. Thomas, & Douglas A. Greene. (1998). Pathogenesis of Diabetic Neuropathy. Humana Press eBooks. 4(6). 13–48. 104 indexed citations
3.
Sima, Anders A. F., Helen Ristic, Alan Merry, et al.. (1996). Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.. Journal of Clinical Investigation. 97(8). 1900–1907. 78 indexed citations
4.
Stevens, M. J., S. A. Lattimer, Eva L. Feldman, et al.. (1996). Acetyl-l-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat. Metabolism. 45(7). 865–872. 61 indexed citations
5.
Shindo, Hiroko, T. Thomas, Dennis Larkin, et al.. (1996). Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells.. Journal of Clinical Investigation. 97(3). 736–745. 38 indexed citations
6.
Stevens, M. J., Eva L. Feldman, & D. A. Greene. (1995). The Aetiology of Diabetic Neuropathy: the Combined Roles of Metabolic and Vascular Defects. Diabetic Medicine. 12(7). 566–579. 130 indexed citations
7.
Catnach, S M, Anne Ballinger, M. J. Stevens, et al.. (1993). Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy.. Gut. 34(8). 1123–1127. 24 indexed citations
8.
Greene, D. A., Anders A. F. Sima, M. J. Stevens, et al.. (1993). Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage. Diabetes/Metabolism Reviews. 9(3). 189–217. 60 indexed citations
9.
Thomas, T., Eva L. Feldman, Jun Nakamura, et al.. (1993). Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture.. Proceedings of the National Academy of Sciences. 90(20). 9712–9716. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026